Navigation Links
Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities
Date:6/17/2013

s document contains forward-looking statements relating to the Company's results of operations.  The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements.  Statements relating to future results of operations in this document reflect the current views of management.  However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934.  The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

About Hanger, Inc. – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market.  Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 730 locations nationwide.  Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions.  Steeped in over 150 years of clinical excellence and innovation, Hanger's vision is to be the partner of choice for products and services that enhance human physical capability.  For more information on
'/>"/>

SOURCE Hanger, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
2. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
3. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
4. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
5. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
6. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
7. Hanger, Inc. Has Record Year In O&P Acquisitions:
8. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
9. Hanger Files Form 10-K for Year Ended December 31, 2012
10. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
11. Hanger Reports First Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" or the ... hospital management solution provider and operator of the largest ... China , today announced that on July ... cash dividend of US$0.30 per ordinary share (or US$0.90 ... ordinary shares. The total expense for the special dividend ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... allergic,asthma attacks and further define Xolair safety profile in ... up to their 12th birthday, - Xolair is ... associated,with approximately 78% of childhood asthma, - Allergic ... the age,of 18, - Xolair is currently approved ...
... SPEX ) reported that patient recruitment for its ... drug, Naturlose(R), has begun in,India. Expectations for India are ... for the pivotal Phase 3 trial. "Now that enrollment ... 3 trial will be completed,on schedule as reported during ...
Cached Medicine Technology:Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 2Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 3Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 4Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 5Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 6Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 7Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2
(Date:7/28/2014)... 28, 2014 (HealthDay News) -- British researchers report that ... fewer germs around. In their experiments, the scientists ... germs from one person to the other than what ... more casual exchange might suffice as a cultural substitute ... are published in the August issue of the ...
(Date:7/28/2014)... July 28, 2014 Parker Waichman LLP, a ... to ensure that the heroes of 9/11 are never forgotten, ... announced an important deadline. According to a VCF message ... a covered cancer on or before October 12, 2012 must ... First responders and others who were allegedly injured by the ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... relieve sleep apnea in children, but a new study confirms ... if they,re already overweight. The researchers said that,s a ... of health problems -- including, ironically, sleep apnea. But they,re ... Instead, they said, doctors and parents should be aware that ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Sarasota-based FCCI ... Best Companies To Work For. Still headquartered in Sarasota ... the only Florida-domiciled company in the top ten of ... Companies list appears in the August issue of Florida ... and large employer categories. Ranked #7 for 2014, FCCI ...
(Date:7/28/2014)... improving treatment for patients with one of the UK,s ... boost. , Chronic obstructive pulmonary disease (COPD) is the ... difficulties due to long-term damage to the lungs. ... per cent of all hospital admissions in the UK, ... hospital after they are discharged. , A ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 2Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3
... termed ripples and fast ripples, recorded by intracranial ... the localization of the brain region responsible for ... in Epilepsia , a journal of the ... brain regions containing fast ripples, along with the ...
... clinical associate professor of psychiatry and director of the ... School of Medicine (BUSM), has been selected as the ... Training by the Association of Psychology Postdoctoral and Internship ... during the American Psychological Association,s Convention in Washington, DC, ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) -- The ... -- pregnancy has increased dramatically in recent years, according to ... the rate of pregnancy-related stroke hospitalizations went up by 54 ... see some increase in pregnancy-related stroke, but we did not ...
... , THURSDAY, July 28 (HealthDay News) -- Children ... of developing blood cancers -- such as leukemia, multiple ... new study contends. The researchers pointed out that ... and effect can be established, but they suggested that ...
... University of North Carolina-led international study shows that among ... of human papillomavirus-associated precancerous lesions of the penis. Human ... that plays an important role in genital cancers in ... cervix. Jennifer Smith, PhD, senior author, says, "Our ...
... July 28 (HealthDay News) -- Increasing your muscle mass can ... study suggests. Researchers analyzed data from 13,644 adults who ... Survey III between 1988 and 1994. They found that for ... -- the ratio of muscle mass to total body weight ...
Cached Medicine News:Health News:Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children 2Health News:Pregnancy-Related Strokes Jump 54 Percent 2Health News:Pregnancy-Related Strokes Jump 54 Percent 3Health News:Growing Up Near Livestock Tied to Blood Cancers 2Health News:Male circumcision lowers prevalence of penile precancerous lesions among African men 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: